[go: up one dir, main page]

EA200602092A1 - Способ и композиция для лечения ринита - Google Patents

Способ и композиция для лечения ринита

Info

Publication number
EA200602092A1
EA200602092A1 EA200602092A EA200602092A EA200602092A1 EA 200602092 A1 EA200602092 A1 EA 200602092A1 EA 200602092 A EA200602092 A EA 200602092A EA 200602092 A EA200602092 A EA 200602092A EA 200602092 A1 EA200602092 A1 EA 200602092A1
Authority
EA
Eurasian Patent Office
Prior art keywords
rhinitis
treatment
composition
compositions
nasal
Prior art date
Application number
EA200602092A
Other languages
English (en)
Other versions
EA014752B1 (ru
Inventor
Лена Пересветофф-Морат
Андерс Карлсон
Original Assignee
Биолипокс Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Биолипокс Аб filed Critical Биолипокс Аб
Publication of EA200602092A1 publication Critical patent/EA200602092A1/ru
Publication of EA014752B1 publication Critical patent/EA014752B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Предлагаются фармацевтические композиции для лечения ринита, например, с помощью назального или глазного введения, включающие цвиттерионный цетиризин, полярную липидную липосому и фармацевтический приемлемый водный носитель. Композиции по своей природе предпочтительно являются гомогенными.
EA200602092A 2004-05-11 2005-05-06 Способ и композиция для лечения ринита EA014752B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/842,433 US20050255154A1 (en) 2004-05-11 2004-05-11 Method and composition for treating rhinitis
PCT/GB2005/001758 WO2005107711A2 (en) 2004-05-11 2005-05-06 Method and composition for treating rhinitis

Publications (2)

Publication Number Publication Date
EA200602092A1 true EA200602092A1 (ru) 2007-06-29
EA014752B1 EA014752B1 (ru) 2011-02-28

Family

ID=34968224

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602092A EA014752B1 (ru) 2004-05-11 2005-05-06 Способ и композиция для лечения ринита

Country Status (24)

Country Link
US (3) US20050255154A1 (ru)
EP (1) EP1771155B1 (ru)
JP (1) JP4976283B2 (ru)
CN (2) CN1984643A (ru)
AT (1) ATE550015T1 (ru)
AU (1) AU2005239866B2 (ru)
BR (1) BRPI0510778B8 (ru)
CA (1) CA2536728C (ru)
CY (1) CY1112981T1 (ru)
DK (1) DK1771155T3 (ru)
EA (1) EA014752B1 (ru)
ES (1) ES2395130T3 (ru)
HR (1) HRP20120484T1 (ru)
IL (1) IL179012A (ru)
ME (1) ME01436B (ru)
MX (1) MXPA06013121A (ru)
NO (1) NO335840B1 (ru)
NZ (1) NZ550412A (ru)
PL (1) PL1771155T3 (ru)
PT (1) PT1771155E (ru)
RS (1) RS52311B (ru)
SI (1) SI1771155T1 (ru)
WO (1) WO2005107711A2 (ru)
ZA (1) ZA200608407B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060484A1 (es) 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
NZ563373A (en) 2005-06-09 2012-06-29 Meda Ab Method and composition for treating inflammatory disorders
FR2900576B1 (fr) * 2006-05-03 2008-09-19 Centre Nat Rech Scient Procede de concentration extemporanee et reversible de liposomes.
WO2007144902A1 (en) * 2006-06-12 2007-12-21 Jubliant Organosys Limited Chewable bilayer tablet formulation
EP2219652B1 (en) * 2007-11-16 2012-04-25 Baylor College Of Medicine Phospholipid compositions and uses thereof
EP2296711A2 (en) * 2008-05-29 2011-03-23 MDRNA, Inc. Multi-arm amines and uses thereof
PT3943069T (pt) 2009-03-17 2025-02-21 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8524692B2 (en) * 2010-04-29 2013-09-03 Georgia Health Sciences University Research Institute, Inc. Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof
JP2013535456A (ja) * 2010-07-28 2013-09-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器系及び炎症性疾患の治療用医薬組成物
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
KR101475776B1 (ko) * 2012-08-24 2014-12-24 영진약품공업 주식회사 이중 포화 인지질을 포함하는 안정한 피부 외용 조성물
CN104887635B (zh) * 2015-05-20 2019-06-11 苏州东瑞制药有限公司 一种盐酸西替利嗪片及其制备工艺
CN109639410B (zh) 2018-10-31 2021-04-06 创新先进技术有限公司 基于区块链的数据存证方法及装置、电子设备
US20220395438A1 (en) * 2019-11-04 2022-12-15 Universitat Autonoma De Barcelona Tooth whitening composition
CN114392235B (zh) * 2022-01-28 2023-06-27 成都大学 盐酸西替利嗪眼用脂质体、原位凝胶及其制备方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US5141674A (en) * 1984-03-08 1992-08-25 Phares Pharmaceutical Research N.V. Methods of preparing pro-liposome dispersions and aerosols
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
GB8522964D0 (en) 1985-09-17 1985-10-23 Biocompatibles Ltd Aerosol
WO1987007506A1 (en) 1986-06-12 1987-12-17 The Liposome Company, Inc. Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
ES2036593T3 (es) 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
SE8603812D0 (sv) 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
CA2056435A1 (en) 1989-05-15 1990-11-16 Thomas D. Madden Accumulation of drugs into liposomes by a proton gradient
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
RO116341B1 (ro) * 1993-11-16 2001-01-30 Depotech Corp La Jolia Lipozom multivezicular si procedeu de obtinere a acestuia
DE4341472A1 (de) 1993-12-02 1995-06-08 Schering Ag Verfahren zur Erhöhung der Stabilität von hydrophile Wirkstoffe enthaltenden Liposomensuspensionen
DK0744939T3 (da) 1994-02-04 2003-02-03 Lipocore Holding Ab Dobbeltlagspræparationer fremstillet af galactolipid indeholdende digalactosyldiacylglycerol
US6773719B2 (en) * 1994-03-04 2004-08-10 Esperion Luv Development, Inc. Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
WO1996009297A1 (en) * 1994-09-23 1996-03-28 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell inflammatory condition
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US5783566A (en) * 1996-05-10 1998-07-21 California Institute Of Technology Method for increasing or decreasing transfection efficiency
BR9709650A (pt) 1996-06-04 1999-08-10 Procter & Gamble Aerosol nasal contendo um esteróide intransal e um anti-histamínico
US5958378A (en) 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
TW497974B (en) 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
WO1998048839A1 (en) 1997-04-30 1998-11-05 Warner-Lambert Company Topical nasal antiinflammatory compositions
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
JP2002507917A (ja) * 1997-07-04 2002-03-12 トルサナ オステオポロシス ダイアグノスティクス アクティーゼルスカブ 脊椎動物の骨質又は骨格状態を評価するための方法
TR200101790T2 (tr) * 1998-12-23 2001-10-22 Idea Ag. Yayılgan olmayan in vivo topik uygulamalar için geliştirilmiş formül
GR1003359B (el) 1998-12-24 2000-04-10 �.�. ����������� �.�.�.�. Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου
US6613352B2 (en) * 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
WO2001082892A2 (de) * 2000-05-02 2001-11-08 Pharmacept Gmbh Wirkstoffhaltige liposome
PT1347743E (pt) 2000-12-07 2006-06-30 Univ Utrecht Holding Bv Composicao para o tratamento de doencas inflamatorias
US20030144336A1 (en) * 2001-08-27 2003-07-31 Pfizer Inc. Method of selecting nonsedating H1-antagonists
US20030054030A1 (en) * 2001-09-13 2003-03-20 Gary Gordon Method and compositions for the treatment of pruritus
CN1599625A (zh) 2001-12-05 2005-03-23 爱尔康公司 H1拮抗剂和安全类固醇治疗鼻炎的用途
WO2003097100A1 (en) 2002-05-15 2003-11-27 Engelbrecht, Edna Topical composition for the treatment of inflammatory conditions of the skin
EP1371362A1 (en) 2002-06-12 2003-12-17 Universiteit Utrecht Holding B.V. Composition for treatment of inflammatory disorders
AU2003261362A1 (en) * 2002-08-02 2004-02-23 University Of Massachusetts Lipid binding molecules and methods of use
JP2004168709A (ja) * 2002-11-20 2004-06-17 Nidek Co Ltd 抗アレルギー点眼点鼻用組成物
WO2004069338A1 (en) * 2003-01-31 2004-08-19 Schering Corporation Use of combinations of h1 and h3 histamine receptor antagonists for the preparation of a medicament for the treatment of allergic skin and allergic ocular conditions
US20050112199A1 (en) * 2003-09-24 2005-05-26 Mahesh Padval Therapeutic regimens for administering drug combinations
US20080063699A1 (en) 2003-10-15 2008-03-13 Michael Teifel Method of Administering Cationic Liposomes Comprising an Active Drug
JP2005170923A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法

Also Published As

Publication number Publication date
DK1771155T3 (da) 2012-07-09
IL179012A (en) 2014-11-30
US20070026058A1 (en) 2007-02-01
US20180104238A9 (en) 2018-04-19
CN1984643A (zh) 2007-06-20
US20050255154A1 (en) 2005-11-17
BRPI0510778B1 (pt) 2020-03-10
CA2536728A1 (en) 2005-11-17
PT1771155E (pt) 2012-05-15
SI1771155T1 (sl) 2012-09-28
WO2005107711A2 (en) 2005-11-17
ES2395130T3 (es) 2013-02-08
IL179012A0 (en) 2007-03-08
CN103271910A (zh) 2013-09-04
EP1771155A2 (en) 2007-04-11
US20130039969A1 (en) 2013-02-14
NO20064521L (no) 2007-02-06
HRP20120484T1 (hr) 2012-07-31
ME01436B (me) 2012-12-31
EA014752B1 (ru) 2011-02-28
BRPI0510778A (pt) 2007-11-20
CN103271910B (zh) 2018-11-06
ZA200608407B (en) 2007-12-27
EP1771155B1 (en) 2012-03-21
CY1112981T1 (el) 2016-04-13
AU2005239866A1 (en) 2005-11-17
CA2536728C (en) 2011-02-01
JP4976283B2 (ja) 2012-07-18
US9980959B2 (en) 2018-05-29
PL1771155T3 (pl) 2012-08-31
AU2005239866B2 (en) 2010-03-04
WO2005107711A3 (en) 2006-03-16
JP2007537220A (ja) 2007-12-20
MXPA06013121A (es) 2007-05-16
NZ550412A (en) 2010-08-27
RS52311B (en) 2012-12-31
ATE550015T1 (de) 2012-04-15
BRPI0510778B8 (pt) 2021-05-25
NO335840B1 (no) 2015-03-02
HK1098960A1 (en) 2007-08-03

Similar Documents

Publication Publication Date Title
NO20064521L (no) Framgangsmate og blanding for behandling av rhinitt
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
DE602006006308D1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
BRPI0416801A (pt) derivados de 1h-imidazoquinolina como inibidores de proteìna sinase
NO20075136L (no) Nye liposompreparater
NO20064584L (no) Tetrahydropyridoindolderivater
NO20065904L (no) Terapeutiske forbindelser
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
NO20081878L (no) Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
ATE412402T1 (de) Ophthalmische suspension aus einem ophthalmischen arzneimittel, einem poloxamin und glykol- tonizitätsanpassenden mittel, verwendung der zusammensetzung zur herstellung eines medikaments zur behandlung von augenerkrankungen
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
EA200602137A1 (ru) Гидрогелевые препараты интерферона
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
NO20080035L (no) Benzooksazol-2-on derivater som lipase og fosfolipaseinhibitorer
CY1106409T1 (el) Παραγωγα κινολινης
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
EA200602154A1 (ru) Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5
SE0303135D0 (sv) Controlled food effect composition
CY1108191T1 (el) Χρηση λεβοκετιρισινης για την θεραπεια επιμονης αλλεργικης ρινιτιδας
FR2860234B1 (fr) Nouveaux derives 666 du thioxylose
EA200970293A1 (ru) Новые производные 5-тиоксилопиранозы